Whole Genome Sequencing in Breast Cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0008426
- Lead Sponsor
- Genome Insight
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1200
Inclusion Criteria
? Patients who consented to the subject consent form and human derived materials consent form
? Patients aged 19 years or older on the date of signing the consent form
? Patients with the ability to give written consent to voluntarily participate in this study
? Patients who can collect specimens through biopsy and surgical procedure
? A patient with histologically confirmed breast cancer or a patient who has cancer findings through imaging and undergoes a biopsy for pathological confirmation
Exclusion Criteria
? Patients who do not understand or do not consent to written consent
? Patients who are unable to obtain sufficient specimens
? Patients who do not consent to genetic testing
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification and evaluation of individual genetic characteristics of breast cancer patients through whole genome analysis and observation items
- Secondary Outcome Measures
Name Time Method Correlation evaluation between whole genome analysis results and genetic subtypes of cancer